![](https://www.ft.com/__origami/service/image/v2/images/raw/https://d6c748xw2pzm8.cloudfront.net/prod/3f825170-6aa4-11ee-99ad-1d7039d52dfc-standard.png?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1)
EU delays approval of Novavax’s revised Covid jab
Liberate the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter.EU regulators have behind schedule a choice to approve Novavax’s variant-tailored Covid-19 vaccine, in